413 related articles for article (PubMed ID: 22734108)
1. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M
Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108
[TBL] [Abstract][Full Text] [Related]
2. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
3. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
Kundhal K; Lok CE
Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and cardiovascular risk.
Yerram P; Karuparthi PR; Hesemann L; Horst J; Whaley-Connell A
J Am Soc Hypertens; 2007; 1(3):178-84. PubMed ID: 20409850
[TBL] [Abstract][Full Text] [Related]
5. Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention.
Basile JN
South Med J; 2007 May; 100(5):499-505. PubMed ID: 17534087
[TBL] [Abstract][Full Text] [Related]
6. The German Chronic Kidney Disease (GCKD) study: design and methods.
Eckardt KU; Bärthlein B; Baid-Agrawal S; Beck A; Busch M; Eitner F; Ekici AB; Floege J; Gefeller O; Haller H; Hilge R; Hilgers KF; Kielstein JT; Krane V; Köttgen A; Kronenberg F; Oefner P; Prokosch HU; Reis A; Schmid M; Schaeffner E; Schultheiss UT; Seuchter SA; Sitter T; Sommerer C; Walz G; Wanner C; Wolf G; Zeier M; Titze S
Nephrol Dial Transplant; 2012 Apr; 27(4):1454-60. PubMed ID: 21862458
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
De Serres SA; Varghese JC; Levin A
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
[TBL] [Abstract][Full Text] [Related]
8. Risk prediction in chronic kidney disease: pitfalls and caveats.
Rigatto C; Sood MM; Tangri N
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
[TBL] [Abstract][Full Text] [Related]
9. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
Onuigbo MA
Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
[TBL] [Abstract][Full Text] [Related]
10. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
Roberts MA; Hare DL; Ratnaike S; Ierino FL
Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
[TBL] [Abstract][Full Text] [Related]
12. Is there a future for direct renin inhibitors?
Chaudhary K; Nistala R; Whaley-Connell A
Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486
[TBL] [Abstract][Full Text] [Related]
13. [Chronic renal insufficiency and cardiovascular disease].
Charriere S; Rognant N; Chiche F; Cremer A; Deray G; Priou M
Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
Chijioke A; Makusidi AM; Kolo PM
Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.
Stenvinkel P
J Intern Med; 2010 Nov; 268(5):456-67. PubMed ID: 20809922
[TBL] [Abstract][Full Text] [Related]
16. Genetic studies in chronic kidney disease: interpretation and clinical applicability.
Witasp A; Nordfors L; Carrero JJ; Luttropp K; Lindholm B; Schalling M; Stenvinkel P
J Nephrol; 2012; 25(6):851-64. PubMed ID: 23042432
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular biomarkers in chronic kidney disease.
Park SH; Stenvinkel P; Lindholm B
J Ren Nutr; 2012 Jan; 22(1):120-7. PubMed ID: 22200428
[TBL] [Abstract][Full Text] [Related]
19. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?
Yildirim T; Arici M; Piskinpasa S; Aybal-Kutlugun A; Yilmaz R; Altun B; Erdem Y; Turgan C
Ren Fail; 2012; 34(9):1095-9. PubMed ID: 22950572
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and its relationship with chronic kidney disease.
Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
